"granules-india"

Says there has been a steep decline in Covid cases at all its facilities across Hyderabad and Vizag

The drug firm plans to invest about Rs 180 crore on a Multiple Units Pellet System (MUPS) block, around Rs 250 crore on expanding active pharmaceutical ingredients (API) capacity.

Consolidated revenue from operations of the company stood at Rs 799 crore for the quarter under consideration

Hyderabad-based pharmaceutical company building capacities and product pipeline

Board of Directors at their meeting has approved to incorporate a wholly-owned subsidiary of the company in Hyderabad, India to build a greenfield facility for formulations business

Minister said the State government was attracting investments even during the Covid-19 pandemic due to its continuous efforts over a period of time

Granules India, Laurus Labs to set up new manufacturing facilities for finished dosages and formulations, respectively

Receives USFDA nod for generic K-Dur, which is used to treat and prevent low potassium levels in blood

Long-term investments in backward and forward integration from active pharmaceutical ingredients to finished dosages aid growth